WallStSmart

Aveanna Healthcare Holdings Inc (AVAH)vsDaVita HealthCare Partners Inc (DVA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 438% more annual revenue ($14.01B vs $2.60B). AVAH leads profitability with a 10.6% profit margin vs 6.0%. AVAH trades at a lower P/E of 10.7x. DVA earns a higher WallStSmart Score of 70/100 (B).

AVAH

Buy

61

out of 100

Grade: C+

Growth: 8.0Profit: 7.5Value: 5.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.95

DVA

Strong Buy

70

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVAHSignificantly Overvalued (-70.9%)

Margin of Safety

-70.9%

Fair Value

$4.67

Current Price

$12.41

$7.74 premium

UndervaluedFair: $4.67Overvalued
DVAOvervalued (-12.9%)

Margin of Safety

-12.9%

Fair Value

$127.80

Current Price

$178.47

$50.67 premium

UndervaluedFair: $127.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVAH3 strengths · Avg: 9.3/10
P/E RatioValuation
10.7x10/10

Attractively priced relative to earnings

Return on EquityProfitability
36.8%10/10

Every $100 of equity generates 37 in profit

EPS GrowthGrowth
38.5%8/10

Earnings expanding 38.5% YoY

DVA5 strengths · Avg: 9.6/10
PEG RatioValuation
0.4510/10

Growing faster than its price suggests

Return on EquityProfitability
81.0%10/10

Every $100 of equity generates 81 in profit

EPS GrowthGrowth
55.8%10/10

Earnings expanding 55.8% YoY

Debt/EquityHealth
-14.0910/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Areas to Watch

AVAH3 concerns · Avg: 2.3/10
Price/BookValuation
9.4x4/10

Trading at 9.4x book value

Altman Z-ScoreHealth
0.952/10

Distress zone — elevated risk

Debt/EquityHealth
5.241/10

Elevated debt levels

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
6.0%3/10

6.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AVAH

The strongest argument for AVAH centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.

Bull Case : DVA

The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.45 suggests the stock is reasonably priced for its growth.

Bear Case : AVAH

The primary concerns for AVAH are Price/Book, Altman Z-Score, Debt/Equity. Debt-to-equity of 5.24 is elevated, increasing financial risk.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

AVAH carries more volatility with a beta of 1.97 — expect wider price swings.

AVAH is growing revenue faster at 13.7% — sustainability is the question.

DVA generates stronger free cash flow (320M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DVA scores higher overall (70/100 vs 61/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aveanna Healthcare Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Want to dig deeper into these stocks?